A longitudinal analysis of humoral immune responses in patients with COVID-19 with varying disease severities reveals that mortality does not correlate with antiviral antibody levels but, instead, with slower seroconversion.
- Carolina Lucas
- Jon Klein
- Akiko Iwasaki